α2-macroglobulin expression in neuritic-type plaques in patients with Alzheimer's disease
- 30 June 1993
- journal article
- Published by Elsevier in Neurobiology of Aging
- Vol. 14 (3) , 233-237
- https://doi.org/10.1016/0197-4580(93)90006-w
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- α2‐Macroglobulin and other proteinase inhibitors do not interfere with the secretion of amyloid precursor protein in mouse neuroblastoma cellsFEBS Letters, 1992
- The amyloid β protein precursor or proteinase nexin II from mouse is closer related to its human homolog than previously reportedBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1991
- IL-6-mediated events in Alzheimer's disease pathologyImmunology Today, 1991
- Interleukin‐6 and α‐2‐macroglobulin indicate an acute‐phase state in Alzheimer's disease corticesFEBS Letters, 1991
- Exact cleavage site of Alzheimer amyloid precursor in neuronal PC-12 cellsNeuroscience Letters, 1991
- Alpha 2‐macroglobulin synthesis in interleukin‐6‐stimulated human neuronal (SH‐SY5Y neuroblastoma) cells Potential significance for the processing of Alzheimer β‐amyloid precursor proteinFEBS Letters, 1991
- Pathological proteins Tau 64 and 69 are specifically expressed in the somatodendritic domain of the degenerating cortical neurons during Alzheimer's diseaseActa Neuropathologica, 1990
- Cleavage of Amyloid β Peptide During Constitutive Processing of Its PrecursorScience, 1990
- Potential roles of protease inhibitors in Alzheimer's diseaseNeurobiology of Aging, 1989
- Immunochemical identification of the serine protease inhibitor α1-antichymotrypsin in the brain amyloid deposits of Alzheimer's diseaseCell, 1988